<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "pentamidine inj VIAL">
<dose><value>4</value>
<value>300</value>
<value>2 - 4</value>
</dose><route><value>IM</value>
<value>INH</value>
<value>IV</value>
<value>IV </value>
</route><form><value>inj VIAL</value>
</form><drugname><value>pentamidine inj VIAL</value>
</drugname><strength><value>300 mg</value>
</strength><frequency><value>DAILY</value>
<value>EVERY 2 WEEKS</value>
<value>EVERY 3 WEEKS</value>
<value>EVERY 4 WEEKS</value>
<value>MONTHLY</value>
<value>WEEKLY</value>
<value>TWO TIMES WEEKLY</value>
</frequency><instruction><value>Administer by Respirgard II nebulizer.</value>
</instruction><volume></volume><units><value>mg/kg</value>
<value>mg</value>
</units><additionalnotes><value>Recommended treamtment is 14 days. Benefits and risks of treament for longer than 14 days are not well defined.</value>
<value>Recommend treatment until lesions heal.</value>
</additionalnotes><population><value>CHILDREN. Treatment of Pneumocystis jiroveci.</value>
<value>CHILDREN. Prophylaxis of Pneumocystis jiroveci.</value>
<value>ADULT. Prophylaxis of Pneumocystis jiroveci.</value>
<value>ADULT. Leishmaniasis, visceral</value>
<value>ADULT. Leishmaniasis, cutaneous</value>
<value>ADULT. Treatment of Pneumocystis jiroveci.</value>
</population><indicationprn></indicationprn><backgroundinformation></backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antiprotozoals, Miscellaneous</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02183080</value>
</din></drug>